TPG Biotech is a growth-stage equity and venture investment platform focused on the biotechnology industry.
TPG Biotech is part of the growth equity and venture investment platform of TPG, the global private investment firm. TPG Biotech targets investments in pharmaceutical discovery and development, medical technology, diagnostics, healthcare and pharmaceutical services, life sciences, as well as industrial applications of biotechnology. TPG Biotech has access to the broader resources of TPG.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 21, 2022
Carisma Therapeutics
|
Series C | $30M | Biotechnology | — |
Mar 1, 2021
Carisma Therapeutics
|
Series B | $12M | Biotechnology | — |
Jan 7, 2021
Carisma Therapeutics
|
Series B | $47M | Biotechnology | — |
Jun 9, 2020
DNAnexus
|
Series G | $100M | Bioinformatics | — |
Feb 6, 2019
DNAnexus
|
Series F | $68M | Bioinformatics | — |